There are two ways. We have access to a normal peer review process when you're publishing things, and we have an access that Dr. Cutler is responsible for, which is the industrial access, based on a fee for service or on paying for using the beam time. Then you are not forced to publish and to tell about your results. That's how all pharmaceutical companies are doing the work. There's too much competition.
On October 30th, 2012. See this statement in context.